**KEY INFORMATION**
**(a) Full name of discloser:**
Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf of its affiliates who are also investment advisors (“Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this Form 8.3.
**(b) Owner or controller of interests and short positions disclosed, if different from 1(a):**
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
**(c) Name of offeror/offeree in relation to whose relevant securities this form relates:**
Spire Healthcare Group PLC
*Use a separate form for each offeror/offeree.*
**(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:**
[Not applicable / No information provided]
**(e) Date position held/dealing undertaken:**
For an opening position disclosure, state the latest practicable date prior to the disclosure: 06 November 2025
**(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?**
If it is a cash offer or possible cash offer, state “N/A”: N/A
—
**2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE**
If there are positions or rights to:
**(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any):**
| Class of relevant security | Interests Owned/Controlled | % | Short Positions | % |
|—————————-|—————————-|—-|—————–|—-|
| 1p ordinary (GB00BNLPYF73) | 12,235,371 | 3.04% | – | – |
– Cash-settled derivatives: None reported
– Stock-settled derivatives (including options) and agreements to purchase/sell: None reported
*Total interests owned and/or controlled: 12,235,371 shares (3.04%).*
*Note: Dimensional Fund Advisors LP and/or its affiliates do not have discretion regarding voting decisions in respect of 35,234 shares included in the total above.*
All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
**(b) Rights to subscribe for new securities (including directors’ and other employee options):**
Class of relevant security in relation to which subscription right exists: [No details provided]
Details, including nature of the rights concerned and relevant percentages: [No details provided]
—
**3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE**
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated.
**(a) Purchases and sales**
| Class of relevant security | Purchase/Sale | Number of securities | Price per unit (GBP) |
|—————————–|—————|———————|———————|
| 1p ordinary (GB00BNLPYF73) | Purchase | 7,445 | 2.2782 |
| 1p ordinary (GB00BNLPYF73) | Sale | 3,738 | 2.2746 |
| 1p ordinary (GB00BNLPYF73) | Sale | 13,758 | 2.2743 |
– There was a transfer out of 5,832 shares of 1p ordinary.
**(b) Cash-settled derivative transactions**
Class of relevant security: [None reported]
Product description e.g. CFD: [None reported]
Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position: [None reported]
Number of reference securities: [None reported]
Price per unit: [None reported]
**(c) Stock-settled derivative transactions (including options)**
(i) Writing, selling, purchasing or varying:
Class of relevant security, product description, number of securities to which option relates, exercise price per unit, type, expiry date, option money paid/received per unit: [None reported]
(ii) Exercise:
Class of relevant security, product description, exercising/exercised against, number of securities, exercise price per unit: [None reported]
**(d) Other dealings (including subscribing for new securities)**
Class of relevant security, nature of dealing e.g. subscription, conversion, details, price per unit (if applicable): [None reported]
—
**4. OTHER INFORMATION**
**(a) Indemnity and other dealing arrangements**
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
*Irrevocable commitments and letters of intent should not be included.*
If there are no such agreements, arrangements or understandings, state “none”: None
**(b) Agreements, arrangements or understandings relating to options or derivatives**
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”: None
**(c) Attachments**
Is a Supplemental Form 8 (Open Positions) attached? NO
—
**Date of disclosure:** 07 November 2025
**Contact name:** Thomas Hone
https://www.globenewswire.com/news-release/2025/11/07/3183407/0/en/Dimensional-Fund-Advisors-Ltd-Form-8-3-SPIRE-HEALTHCARE-GROUP-PLC-Ordinary-Shares.html
